Gan & Lee Pharmaceuticals
IPOPublic · Beijing, China · Founded 1998
- Headquarters
- Beijing
- Employees
- 1001–5000
- Founded
- 1998
- Business Model
- B2B
- Website
- ganlee.com
- Last Round
- Series BJan 2011
- Rounds
- 2
- Type
- Public
About
Chinese biopharmaceutical company that developed the first domestic insulin analog and manufactures a series of recombinant insulin products.
Summary
Gan & Lee Pharmaceuticals is a Healthcare company based in Beijing, China, founded in 1998. Its most recent funding was a Series B round in Jan 2011. Investors include Qiming VP.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2018
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...